PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-23.47%
Both yoy net incomes decline, with VET at -30.05%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
6.36%
D&A growth well above VET's 4.13%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-318.94%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
97.02%
Slight usage while VET is negative at -154.18%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
637.40%
Some yoy increase while VET is negative at -111.33%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
98.00%
Some CFO growth while VET is negative at -55.04%. John Neff would note a short-term liquidity lead over the competitor.
9.45%
CapEx growth of 9.45% while VET is zero at 0.00%. Bruce Berkowitz would see a mild cost burden that must yield returns in future revenue or margins.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
94.44%
Growth well above VET's 98.65%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
25.42%
Investing outflow well above VET's 14.61%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
85.03%
Debt repayment growth of 85.03% while VET is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
746.59%
We slightly raise equity while VET is negative at -96.12%. John Neff sees competitor possibly preserving share count or buying back shares.
-26.20%
We cut yoy buybacks while VET is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.